Compare Flux Power Holdings Inc (FLUX) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs BIO-TECHNE Corp — how do they compare? Flux Power Holdings Inc trades at $0.53 (market cap $11.35M), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 990.3× Flux Power Holdings Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals.
| FLUX | TECH | |
|---|---|---|
Market Cap | $11.35M | $11.24B |
Sector | Utilities | Health |
52-Week High | $6.66 | $72.29 |
52-Week Low | $0.51 | $43.31 |
Enterprise Value | $17.51M | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.535, up 0.66% with a bearish technical signal despite 100% analyst buy ratings. The company reported mixed earnings with Q4 2025 beating expectations but Q1 2026 missing, while revenue declined from $66M in 2025 to $51M in 2026. Recent product launches like SkyEMS 3.0 and executive appointments aim to drive growth amid negative profitability metrics.
The outlook remains challenged by persistent net losses and negative ROE, though low P/S ratio and strong analyst support offer potential upside if operational improvements materialize. Key risks include cash flow volatility and competitive pressure in the clean energy sector.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
